The selection of therapy for patients with castration-resistant prostate cancer (CRPC) remains challenging. Review answers to some of the most important questions posed by your oncology and urology colleagues from a series of live Tumor Boards.
Check your own knowledge with 5 short assessment questions.
Discover the top questions oncologists and urologists have about castration-resistant prostate cancer.
Probe the details of a related patient case.
This activity was developed for hospital-based oncologists and urologists, community cancer center oncologists, oncology fellows and other health care professionals involved in the management of patients with castration-resistant prostate cancer (CRPC).